MedPath

sodium nitroprusside

Sodium Nitroprusside Injection

Approved
Approval ID

870b8428-3e48-40f5-9172-d962adc90dd5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 9, 2022

Manufacturers
FDA

Nexus Pharmaceuticals Inc

DUNS: 620714787

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sodium nitroprusside

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code14789-012
Application NumberANDA207499
Product Classification
M
Marketing Category
C73584
G
Generic Name
sodium nitroprusside
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 9, 2022
FDA Product Classification

INGREDIENTS (2)

sodium nitroprussideActive
Quantity: 25 mg in 1 mL
Code: EAO03PE1TC
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

sodium nitroprusside - FDA Drug Approval Details